VCM
ORGS

Venator Capital Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Venator Capital Management’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,325
Closed -$685K – 34
2019
Q3 		$685K Sell
15,325
-15,175
-50% -$677K 0.59% 27
2019
Q2 		$1.36M Buy
30,500
+11,912
+64% +$537K 1.32% 26
2019
Q1 		$991K Buy
+18,588
New +$928K 1.03% 30

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $659M AUM 18.25% 1-Year Est. Return

Venator Capital Management's ORGS Position: Q4 2019 in Review

Venator Capital Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2019, closing a stake of 15,325 shares — an estimated $685K sold.

Venator Capital Management first reported a position in ORGS in Q1 2019 and held it in 3 quarters. The position peaked at $1.36M in Q2 2019. 14 funds tracked by Wall St. Rank hold ORGS as of Q4 2019.

  • Venator Capital Management reported no remaining Orgenesis Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Venator Capital Management sold 15,325 Orgenesis Inc. Common Stock shares in Q4 2019, an estimated $685K.
  • Venator Capital Management first reported a position in Orgenesis Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Venator Capital Management's Orgenesis Inc. Common Stock position peaked at $1.36M in Q2 2019.
  • 14 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2019.

Based on Venator Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.